| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
From the Department of Pediatrics (Drs. Takanashi, Tomita, Kurihara, and Kohno), Radiology (Dr. Morita), Graduate School of Medicine, Chiba University, and Division of Medical Imaging (Drs. Takanashi, Tomita, Ikehira, Tanada, and Yoshitome), National Institute of Radiological Sciences, Chiba, Japan; and Department of Molecular and Human Genetics, Baylor College of Medicine (Dr. Inoue), Houston, TX.
Address correspondence and reprint requests to Dr. Jun-ichi Takanashi, Department of Pediatrics, Graduate School of Medicine, Chiba University, 1-8-1 Inohana, Chuo-ku, Chiba-shi, Chiba 260-8670, Japan; e-mail: jtaka{at}med.m.chiba-u.ac.jp
Objective: To assess alterations in brain metabolites of patients with Pelizaeus–Merzbacher disease (PMD) with the proteolipid protein gene 1 (PLP1) duplications using quantitative proton MRS.
Methods: Five unrelated male Japanese patients with PMD with PLP1 duplications were analyzed using automated proton brain examination with the point resolved spectroscopy technique (repetition and echo time of 5,000 and 30 msec). Localized spectra in the posterior portion of the centrum semiovale were acquired, and absolute metabolite concentrations were calculated using the LCModel.
Results: Absolute concentrations of N-acetylaspartate (NAA), creatine (Cr), and myoinositol (MI) were increased by 16% (p < 0.01), 43% (p < 0.001), and 31% (p < 0.01) in patients with PMD as compared with age-matched controls. There was no statistical difference in choline concentration.
Conclusion: The increased concentration of NAA, which could not be detected by previous relative quantitation methods, suggests two possibilities: axonal involvement secondary to dysmyelination, or increased cell population of oligodendrocyte progenitors. Elevated Cr and MI concentrations may reflect the reactive astrocytic gliosis. Our study thus emphasizes the importance of absolute quantitation of metabolites to investigate the disease mechanism of the dysmyelinating disorders of the CNS.
This article has been cited by other articles:
|
|
 |
|
  F. A. Hanefeld, K. Brockmann, P.J.W. Pouwels, B. Wilken, J. Frahm, and P. Dechent Quantitative proton MRS of Pelizaeus-Merzbacher disease: Evidence of dys- and hypomyelination Neurology, September 13, 2005; 65(5): 701 - 706. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. G. Steen and R. J. Ogg Abnormally High Levels of Brain N-Acetylaspartate in Children with Sickle Cell Disease AJNR Am. J. Neuroradiol., March 1, 2005; 26(3): 463 - 468. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
N. I. Wolf, M. A.A.P. Willemsen, U. F. Engelke, M. S. van der Knaap, P. J.W. Pouwels, I. Harting, J. Zschocke, E. A. Sistermans, D. Rating, and R. A. Wevers Severe hypomyelination associated with increased levels of N-acetylaspartylglutamate in CSF Neurology, May 11, 2004; 62(9): 1503 - 1508. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Pizzini, Ali. S. Fatemi, P. B. Barker, L. M. Nagae-Poetscher, A. Horska, A. W. Zimmerman, H. W. Moser, G. Bibat, and S. Naidu Proton MR Spectroscopic Imaging in Pelizaeus-Merzbacher Disease AJNR Am. J. Neuroradiol., September 1, 2003; 24(8): 1683 - 1689. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Takanashi, A. Kurihara, M. Tomita, M. Kanazawa, S. Yamamoto, F. Morita, H. Ikehira, S. Tanada, and Y. Kohno Distinctly abnormal brain metabolism in late-onset ornithine transcarbamylase deficiency Neurology, July 23, 2002; 59(2): 210 - 214. [Abstract] [Full Text] [PDF]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
